Rxsight
Calhoun Vision is focused on developing vision correction technologies for post-cataract surgery patients.
Launch date
Employees
Market cap
-
Enterprise valuation
€95m (Public information from Apr 2020)
Pasadena California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $8.5m | Debt | |
| N/A | $5.1m | Debt | |
| N/A | $12.7m | Debt | |
$17.0m | Debt | ||
$52.0m | Debt | ||
$21.0m | Series H | ||
$9.6m Valuation: $105m | Late VC | ||
* | $60.0m | Debt | |
| N/A | N/A | IPO | |
| N/A | $50.0m | Post IPO Equity | |
* | N/A | N/A | Post IPO Equity |
| Total Funding | €27.8m | ||
Related Content
Recent News about Rxsight
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.